Innate cellular antiviral defences present a significant challenge to viral vector production and transduction for cell and gene therapy manufacturing.
Learn about what they are, the challenges they pose and Virica’s solution to mitigating its impact on viral vector yield and quality.
View infographic here: Antiviral Defenses: What You Need to Know